Instituto de Investigación Sanitaria Galicia Sur (IISGS)
Centro de investigación
Jagiellonian University
Cracovia, PoloniaPublicacións en colaboración con investigadores/as de Jagiellonian University (20)
2023
-
Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients
European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 1, pp. 22-37
-
Worldwide survey on implantation of and outcomes for conduction system pacing with His bundle and left bundle branch area pacing leads
Journal of Interventional Cardiac Electrophysiology, Vol. 66, Núm. 7, pp. 1589-1600
2022
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study
European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316
2021
-
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78
-
Evaluating the Impact of COVID-19 on the adoption of virtual care in general practice in 20 countries (inSIGHT): Protocol and rationale study
JMIR Research Protocols, Vol. 10, Núm. 8
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
-
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749
-
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: The ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
European Heart Journal, Vol. 42, Núm. 44, pp. 4536-4549
2020
-
Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five-year clinical outcomes of the randomised ABSORB II trial
EuroIntervention, Vol. 16, Núm. 11, pp. E938-E941
-
Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent
Atherosclerosis, Vol. 312, pp. 79-89
2019
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study
EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252
2018
-
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
EuroIntervention, Vol. 13, Núm. 13, pp. 1561-1564
-
Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO
Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227
2017
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134
-
Comparison of everolimus-eluting bioresorbable scaffolds with everolimuseluting metallic stents for treatment of coronary artery stenosis: Three-year follow-up of the ABSORB II randomized trial
Bioresorbable Scaffolds: From Basic Concept to Clinical Applications (CRC Press), pp. 224-237
-
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
Respiratory Medicine, Vol. 132, pp. 68-75
2016
-
A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy
Cardiovascular Revascularization Medicine, Vol. 17, Núm. 6, pp. 355-361
-
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
The Lancet, Vol. 388, Núm. 10059, pp. 2479-2491
2015
-
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
The Lancet, Vol. 385, Núm. 9962, pp. 43-54